StockData
Gain Therapeutics, Inc. logo

Gain Therapeutics, Inc. (GANX) stock

GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$1.18+0.24 (+25.51%)

Close on Nov 17, 2026Market cap $51.50MP/E –Yield –

Gain Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Gain Therapeutics

Gain Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Gain Therapeutics figures

See a number that looks wrong?